Asahi Kasei Corp (3407):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Asahi Kasei Corp (3407) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9966
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Asahi Kasei Corp (Asahi Kasei), manufactures, and markets chemical products. The product portfolio of the company includes polymers, acrylonitrile, styrene, diagnostic reagents, foam insulation panels, foundation systems, methyl methacrylate, adipic acid, polyethylene, polystyrene, functional additives, membrane filtration systems, ion-exchange membranes, medical devices and sensors. Its products find application in the fields of chemicals and fibers, electronics, healthcare and construction. Asahi Kasei markets its products under various brand names such as Bemberg, Roica, Eltas, Bemliese, Lamous, Eutec and Precise among others. The company has operational presence in North America, Central and South America, Europe, Asia and Oceania. Asahi Kasei is headquartered in Chiyoda-ku, Tokyo, Japan.

Asahi Kasei Corp (3407) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Asahi Kasei Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Asahi Kasei Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Asahi Kasei Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Asahi Kasei Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Asahi Kasei Corp, Medical Devices Deals, 2012 to YTD 2018 9
Asahi Kasei Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Asahi Kasei Corp, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Atox Bio Raises USD30 Million in Financing 12
Xeris Pharma Raises Additional USD30 Million in Series C Financing 14
Advanced Circulatory Systems Raises US$2 Million In Financing 16
Partnerships 17
XERIS Pharma Enters into Agreement with Asahi Kasei Pharma 17
DeNA and DeNA Life Science Enter into Research Partnership with Asahi Kasei Pharma and Shionogi 18
Evotec Enters into Agreement with Asahi Kasei Pharma 19
Orion Enters into Agreement with Asahi Kasei Pharma 20
PeptiDream Enters into Research Agreement with Asahi Kasei Pharma 21
SPI Pharma Enters into Co-Marketing Agreement with Asahi Kasei Chemicals 22
RaQualia Pharma Enters Into Research Agreement With Asahi Kasei Pharma 23
Vernalis Enters Into Drug Discovery Agreement With Asahi Kasei 24
Hisamitsu Pharma Enters Into Co-Marketing Agreement With Asahi Kasei Pharma For HOB-294 25
Licensing Agreements 26
Asahi Kasei Pharma Enters into Licensing Agreement with Sanofi 26
Asahi Kasei Enters into Licensing Agreement with Bone Therapeutics 27
Asahi Kasei Pharma Enters into Licensing Agreement with Array BioPharma 28
Basilea Pharma Enters into Licensing Agreement with Asahi Kasei Pharma 29
Asahi Kasei Pharma Enters into License Agreement with Dong-A ST 30
Debt Offering 31
TherOx Raises Funds through Private Placement 31
Asahi Kasei Corp – Key Competitors 32
Asahi Kasei Corp – Key Employees 33
Asahi Kasei Corp – Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Joint Venture 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Asahi Kasei Corp, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Asahi Kasei Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Asahi Kasei Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Asahi Kasei Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Asahi Kasei Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Asahi Kasei Corp, Medical Devices Deals, 2012 to YTD 2018 9
Asahi Kasei Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Atox Bio Raises USD30 Million in Financing 12
Xeris Pharma Raises Additional USD30 Million in Series C Financing 14
Advanced Circulatory Systems Raises US$2 Million In Financing 16
XERIS Pharma Enters into Agreement with Asahi Kasei Pharma 17
DeNA and DeNA Life Science Enter into Research Partnership with Asahi Kasei Pharma and Shionogi 18
Evotec Enters into Agreement with Asahi Kasei Pharma 19
Orion Enters into Agreement with Asahi Kasei Pharma 20
PeptiDream Enters into Research Agreement with Asahi Kasei Pharma 21
SPI Pharma Enters into Co-Marketing Agreement with Asahi Kasei Chemicals 22
RaQualia Pharma Enters Into Research Agreement With Asahi Kasei Pharma 23
Vernalis Enters Into Drug Discovery Agreement With Asahi Kasei 24
Hisamitsu Pharma Enters Into Co-Marketing Agreement With Asahi Kasei Pharma For HOB-294 25
Asahi Kasei Pharma Enters into Licensing Agreement with Sanofi 26
Asahi Kasei Enters into Licensing Agreement with Bone Therapeutics 27
Asahi Kasei Pharma Enters into Licensing Agreement with Array BioPharma 28
Basilea Pharma Enters into Licensing Agreement with Asahi Kasei Pharma 29
Asahi Kasei Pharma Enters into License Agreement with Dong-A ST 30
TherOx Raises Funds through Private Placement 31
Asahi Kasei Corp, Key Competitors 32
Asahi Kasei Corp, Key Employees 33
Asahi Kasei Corp, Subsidiaries 35
Asahi Kasei Corp, Joint Venture 37

List of Figures
Asahi Kasei Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Asahi Kasei Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Asahi Kasei Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Asahi Kasei Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Asahi Kasei Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Asahi Kasei Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Asahi Kasei Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Asahi Kasei Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Asahi Kasei Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Asahi Kasei Corp (3407):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TPS Eastern Africa Limited:企業の戦略・SWOT・財務情報
    TPS Eastern Africa Limited - Strategy, SWOT and Corporate Finance Report Summary TPS Eastern Africa Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Moser Baer India Ltd (MOSERBAER):企業の財務・戦略的SWOT分析
    Moser Baer India Ltd (MOSERBAER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Taiho Pharmaceutical Co Ltd:企業の戦略的SWOT分析
    Taiho Pharmaceutical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Natco Pharma Ltd (NATCOPHARM):企業の財務・戦略的SWOT分析
    Natco Pharma Ltd (NATCOPHARM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Lenzing AG (LNZ):企業の財務・戦略的SWOT分析
    Lenzing AG (LNZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Old Dominion Electric Cooperative:企業の戦略的SWOT分析
    Old Dominion Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Revance Therapeutics Inc (RVNC):企業の財務・戦略的SWOT分析
    Revance Therapeutics Inc (RVNC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Esperion Therapeutics Inc (ESPR):企業の財務・戦略的SWOT分析
    Summary Esperion Therapeutics Inc (Esperion), a subsidiary of Pfizer Inc is a pharmaceutical company that develops and commercializes once-daily, oral and low-density lipoprotein cholesterol lowering therapies. The company develops oral therapies to treat patients with elevated low-density lipoprote …
  • Wellington Management Company LLP:企業の戦略・SWOT・財務情報
    Wellington Management Company LLP - Strategy, SWOT and Corporate Finance Report Summary Wellington Management Company LLP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Dawnbreaker, Inc.:企業の戦略・SWOT・財務分析
    Dawnbreaker, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dawnbreaker, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Fenchem Inc:企業の戦略・SWOT・財務分析
    Fenchem Inc - Strategy, SWOT and Corporate Finance Report Summary Fenchem Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Unilever Pakistan Limited:企業の戦略・SWOT・財務分析
    Unilever Pakistan Limited - Strategy, SWOT and Corporate Finance Report Summary Unilever Pakistan Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Citibank NA-India Branches:企業の戦略的SWOT分析
    Citibank NA-India Branches - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Nutra Pharma Corp (NPHC):企業の財務・戦略的SWOT分析
    Nutra Pharma Corp (NPHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Banco Nacional de Obras y Servicios Publicos SNC:企業の戦略・SWOT・財務分析
    Banco Nacional de Obras y Servicios Publicos SNC - Strategy, SWOT and Corporate Finance Report Summary Banco Nacional de Obras y Servicios Publicos SNC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Wexford Health Sources Inc:企業の戦略的SWOT分析
    Wexford Health Sources Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • NeuroMetrix Inc (NURO)-医療機器分野:企業M&A・提携分析
    Summary NeuroMetrix Inc (NeuroMetrix) is a medical device company that develops wearable medical technology and point of care test to manage chronic pain, nerve diseases, and sleep disorders. The company’s products include quell wearable pain relief device, SENSUS pain therapy device, NC-stat DPNChe …
  • Foundation Medicine Inc (FMI):製薬・医療:M&Aディール及び事業提携情報
    Summary Foundation Medicine Inc (Foundation Medicine), a subsidiary of F. Hoffmann-La Roche Ltd, is a molecular information products provider. The company provides molecular information and cancer research programs. It offers clinical products such as FoundationOne for solid tumors and FoundationOne …
  • Quantum Corp (QTM):企業の財務・戦略的SWOT分析
    Summary Quantum Corp (Quantum) is a technology company that offers intelligent solutions for capturing, sharing and preserving digital assets over the data lifecycle. The company provides products such as stornext scale-out storage, Q-cloud archive, quantum archives, scalar , LTO Tape Drives, DXi de …
  • Cavion LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Cavion LLC (Cavion), formerly Tau Therapeutics LLC is a clinical stage pharmaceutical company that develops modulators and drugs. The company researches and develops T-type calcium channel (Cav3) inhibitors for the treatment of neurologic and oncologic diseases. It provides pipeline products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆